Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia

Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction

(2020) Tu’uhevaha J. Kaitu’u-Lino et al.   Nature Communications

The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development

(2019) Carole-Anne Whigham et al.   PLACENTA

Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial

(2019) Lucy C Chappell et al.   LANCET

Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women

(2019) Swati Agrawal et al.   HYPERTENSION

Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes

(2017) Offer Erez et al.   Journal of Maternal-Fetal & Neonatal Medicine

Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia

(2017) Barry Kevane et al.   THROMBOSIS AND HAEMOSTASIS

Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study

(2017) Aurélie Di Bartolomeo et al.   PLoS One

Tissue factor-dependent pathway in severe preeclampsia revisited

(2016) Luci M. Dusse et al.   BLOOD COAGULATION & FIBRINOLYSIS

The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review

(2015) Jana Prochazkova et al.   BIOMEDICAL PAPERS-OLOMOUC

Maternal circulating PlGF concentrations and placenta-related pregnancy complications: First results from the CoLab AngF Study

(2013) A.C. Staff et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor

(2012) Lara Carvalho Godoi et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Preeclampsia, a Disease of the Maternal Endothelium

(2011) Camille E. Powe et al.   CIRCULATION

The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients

(2010) Yincheng Teng et al.   THROMBOSIS RESEARCH

Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts

(2009) Yin-Cheng Teng et al.   JOURNAL OF PERINATAL MEDICINE

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial

(2009) Corine M Koopmans et al.   LANCET

Tissue pathway factor inhibitor (TFPI) activity is elevated in pregnant patients at 20 weeks gestation who subsequently develop preeclampsia

(2009) Sarah Hillman et al.   THROMBOSIS AND HAEMOSTASIS